Osteopore Limited (ASX:OSX)
0.0040
0.00 (0.00%)
Sep 11, 2026, 10:02 AM AEST
Osteopore Revenue
Osteopore had revenue of 1.43M AUD in the half year ending June 30, 2026, a decrease of -3.24%. This brings the company's revenue in the last twelve months to 2.93M, up 2.86% year-over-year. In the year 2025, Osteopore had annual revenue of 3.06M with 10.65% growth.
Revenue (ttm)
2.93M
Revenue Growth
+2.86%
P/S Ratio
0.95
Revenue / Employee
n/a
Employees
n/a
Market Cap
2.77M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 3.06M | 294.32K | 10.65% |
| Dec 31, 2024 | 2.76M | 545.37K | 24.60% |
| Dec 31, 2023 | 2.22M | 525.02K | 31.02% |
| Dec 31, 2022 | 1.69M | 579.38K | 52.06% |
| Dec 31, 2021 | 1.11M | -391.57K | -26.03% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| CSL Limited | 22.83B |
| Ramsay Health Care | 18.58B |
| Sigma Healthcare | 10.83B |
| Pro Medicus | 261.69M |
| Global Health | 8.02M |
| Enlitic | 5.20M |
| BPH Global | 3.44M |
| Uscom | 2.41M |